Hematocrit and the Risk of Recurrent Venous Thrombosis: A Prospective Cohort Study

Blood- United States

doi 10.1182/blood.v116.21.807.807

Full Text

Abstract

Available in

Categories

Date

November 19, 2010

Authors

Lisbeth Eischer

Paul Alexander Kyrle

Sabine Eichinger

Publisher

American Society of Hematology

Related search

Hematocrit and the Risk of Recurrent Venous Thrombosis: A Prospective Cohort Study

Multidisciplinary

English

Mild Antithrombin Deficiency and Risk of Recurrent Venous Thromboembolism: A Prospective Cohort Study

Cardiovascular Medicine

English

Statin Therapy and Recurrent Venous Thromboembolism in the Elderly: A Prospective Cohort Study

Scientific Reports

Multidisciplinary

English

Hematocrit and Risk of Venous Thromboembolism in a General Population. The Tromso Study

English

A Prospective Study of Anticardiolipin Antibodies as a Risk Factor for Venous Thrombosis in a General Population (The HUNT Study)

Journal of Thrombosis and Haemostasis

English

Antibiotic Use as a Marker of Acute Infection and Risk of First and Recurrent Venous Thrombosis

British Journal of Haematology

English

Antipsychotics and Risk of Venous Thrombosis

British Journal of Psychiatry

English

Myocardial Infarction, Prothrombotic Genotypes, and Venous Thrombosis Risk: The Tromsø Study

Research and Practice in Thrombosis and Haemostasis

English

Lipid Levels and Risk of Venous Thrombosis: Results From the MEGA-study

European Journal of Epidemiology

English